The FDA has given the green light to a clinical trial testing ATA-200, a gene therapy for limb-girdle muscular dystrophy ...

Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.

Allegations have emerged suggesting that Kate Middleton, the wife of the British crown prince, may have fabricated or ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological ...

Emaritino Echiku, a 75-year-old resident of Soroti District, has been undergoing treatment for breast cancer at the Uganda ...

chemotherapy and radiation therapy, researchers said in background notes. The trial patients all had undergone chemotherapy, ...

T cells, a type of white blood cells, attack and kill infected cells. Immuno Cure said it plans to share its findings in ...

Kebilidi is delivered into the putamen - a part of the brain that is involved with learning, motor control and speech - and ...

Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –– Patient reported efficacy outcomes ...

In a sense, the combination begins to awaken the cells to their purpose within the body. You might say the treatment acts as a template of what is normal for the ... with the Beat and then sent to the ...

A scientist who was diagnosed with stage 3 cancer treated herself using lab-grown viruses, a method researchers say is 'not ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...